In ₹ Crore except Per Share Latest Annual	ACI FY26	NEOGEN FY26	AETHER FY26	ALKYLAMINE FY26	Peer Average
Valuation — at last close
P/E	◆ 52.47×	207.50×	95.53×	—	151.51× -65%
P/B	◆ 2.90×	7.31×	8.54×	—	7.93× -63%
EV/EBITDA	◆ 25.19×	53.00×	58.89×	—	55.94× -55%
Market Cap	₹5,610 Cr	₹5,966 Cr	₹20,977 Cr	—	₹13,472 Cr -58%
Growth
Revenue CAGR 3Y	-9.14%	7.90%	◆ 21.23%	—	14.57% -163%
Revenue CAGR 5Y	—	20.70%	—	—	20.70%
Net Income CAGR 3Y	-34.93%	-16.83%	◆ 20.77%	—	1.97% -1873%
Revenue YoY (latest Q)	27.52%	◆ 34.04%	26.22%	—	30.13% -9%
Net Income YoY (latest Q)	7.90%	◆ 66.76%	26.02%	—	46.39% -83%
Profitability
EBITDA Margin	22.09%	15.96%	◆ 31.34%	—	23.65% -7%
Net Income Margin	9.75%	3.34%	◆ 19.80%	—	11.57% -16%
Return on Common Equity	5.55%	3.58%	◆ 9.38%	—	6.48% -14%
Return on Capital Employed	6.60%	8.07%	◆ 12.29%	—	10.18% -35%
Return on Assets	4.17%	1.24%	◆ 7.86%	—	4.55% -8%
Credit & Quality
Total Debt/Equity	0.24×	1.63×	◆ 0.18×	—	0.90× -73%
Interest Coverage	5.67×	1.47×	◆ 16.43×	—	8.95× -37%
Scale — latest FY
Revenue / Total Income	₹1,081 Cr	₹862 Cr	₹1,160 Cr	—	₹1,011 Cr +7%
Net Income	₹105 Cr	₹28.8 Cr	₹230 Cr	—	₹129 Cr -18%
Total Assets	₹2,665 Cr	₹2,902 Cr	₹3,201 Cr	₹1,895 Cr	₹2,666 Cr 0%
EPS	₹8.66	₹10.9	₹16.55	—	₹13.73 -37%
Book Value per Share	₹156.68	₹309.42	₹185.1	—	₹247.26 -37%

◆ best value in the comp set per metric · Δ = subject vs average of the other companies.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.